查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571832

微生物附著量測試市場規模、佔有率和趨勢分析報告：2024-2030 年按產品、測試、應用、最終用途、地區和細分市場進行的預測

Bioburden Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

微生物附著量測試市場成長與趨勢：

根據Grand View Research, Inc.最新報告，到2030年，全球微生物附著量測試市場規模預計將達到32.2億美元，預測期內複合年成長率為14.3%。

由於對產品安全的擔憂日益加劇，預計未來幾年市場將呈現擴大趨勢。因此，政府正在採取各種措施來推廣微生物安全測試工具。

各組織為提高人們對微生物安全測試的認知而出版的許多出版物正在擴大微生物附著量測試未來成長的前景。例如，美國衛生與公眾服務部和疾病管制中心製定了《醫學實驗室微生物學和生物生物安全（BMBL）》並出版。

製藥、生物技術、醫療設備以及食品和飲料行業的成長推動了微生物附著量測試市場的快速成長。此外，知名公司增加的研發投資預計將鼓勵最終用戶採用高效的微生物附著量測試工具，以應對微生物污染造成的損失。此外，臨床前研究對基本藥物安全資料的需求預計將推動對微生物附著量測試工具的需求。

微生物附著量測試市場報告亮點

  • 從產品來看，由於培養基、試劑和套件的廣泛使用，消耗品領域在 2023 年佔據市場主導地位。
  • PCR 儀器有助於快速分析細菌微生物附著量，進而推動市場快速成長。
  • 由於使用培養基可以輕鬆分離需氣菌需氣菌計數檢測在 2023 年佔據最大的市場佔有率。
  • 由於產品召回的增加和對產品品質的擔憂，預計原料檢驗在預測期內將出現良好的成長。
  • 從最終用途來看，由於該行業的高速成長，製藥和生物技術公司將在 2023 年主導市場。
  • CMO數量大幅增加，導致外包服務增加。
  • 由於主要企業的研發費用較高以及美國的醫療保健支出較高，北美地區在 2023 年佔據了最大的收益佔有率。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章微生物附著量測試市場變數、趨勢、範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 微生物附著量測試市場分析工具
    • 波特的分析
    • PESTEL分析

第4章微生物附著量測試市場：產品估算與趨勢分析

  • 細分儀表板
  • 微生物附著量測試市場：2023 年和 2030 年產品變化分析
  • 消耗品
  • 裝置

第5章微生物附著量測試市場：測試估算與趨勢分析

  • 細分儀表板
  • 微生物附著量測試市場：2023 年和 2030 年測試變異分析
  • 有氧計數測試
  • 厭氧計數測試
  • 真菌/黴菌計數測試
  • 孢子計數測試

第6章微生物附著量測試市場：應用估算與趨勢分析

  • 細分儀表板
  • 微生物附著量測試市場：2023 年和 2030 年應用變化分析
  • 原料檢測
  • 醫療設備測試
  • 進程內材料測試
  • 滅菌檢驗試驗
  • 設備清洗檢驗

第7章微生物附著量測試市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 微生物附著量測試市場：最終用途變化分析，2023 年和 2030 年
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 契約製造組織
  • 食品/飲料/農產品製造商
  • 微生物檢測實驗室

第8章微生物附著量測試市場：區域估計和趨勢分析

  • 2023 年和 2030 年微生物附著量測試市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Charles River Laboratories
    • Merck KGaA
    • SGS Societe Generale de Surveillance SA.
    • WuXi AppTec
    • BD
    • North American Science Associates, LLC
    • Nelson Laboratories, LLC
    • Thermo Fisher Scientific Inc
    • BIOMERIEUX
    • Pacific Biolabs
簡介目錄
Product Code: GVR-3-68038-774-2

Bioburden Testing Market Growth & Trends:

The global bioburden testing market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 14.3% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.

Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.

Bioburden Testing Market Report Highlights:

  • On the basis of product, consumables segment dominated the market in 2023 owing to a wide use of culture media and reagents and kits.
  • The PCR instruments facilitate rapid analysis of bacterial bioburden, thus, fostering high market growth.
  • The aerobic count-testing held largest market share in 2023 due to easy isolation of aerobic bacteria by culture media.
  • Raw material testing is anticipated to showcase lucrative growth during the forecast period owing to the increasing number of product recalls and concern regarding product quality.
  • On the basis of end-use, pharmaceutical and biotechnology companies dominated the market in 2023 owing to the high growth of this industry.
  • The number of CMOs is increasing significantly, which has led to a rise in outsourcing services, thus, driving the segment growth.
  • North America held the largest revenue share in 2023 due to high R&D spending by key companies and high healthcare spending in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioburden Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioburden Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioburden Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioburden Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Culture Media
        • 4.3.1.1.1. Culture Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Reagents and Kits
        • 4.3.1.2.1. Reagents and Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Automated Microbial Identification Systems
        • 4.4.1.1.1. Automated Microbial Identification Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. PCR Instruments
        • 4.4.1.2.1. PCR Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioburden Testing Market: Test Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioburden Testing Market: Test Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Aerobic Count Testing
    • 5.3.1. Aerobic Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Anaerobic Count Testing
    • 5.4.1. Anaerobic Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Fungi/Mold Count Testing
    • 5.5.1. Fungi/Mold Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Spore Count Testing
    • 5.6.1. Spore Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioburden Testing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Bioburden Testing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Raw Material Testing
    • 6.3.1. Raw Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Medical Device Testing
    • 6.4.1. Medical Device Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. In-Process Material Testing
    • 6.5.1. In-Process Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Sterilization Validation Testing
    • 6.6.1. Sterilization Validation Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Equipment Cleaning Validation
    • 6.7.1. Equipment Cleaning Validation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Bioburden Testing Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Bioburden Testing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Medical Device Manufacturers
    • 7.4.1. Medical Device Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Contract Manufacturing Organizations
    • 7.5.1. Contract Manufacturing Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Manufacturers of Food & Beverage and Agricultural Products
    • 7.6.1. Manufacturers of Food & Beverage and Agricultural Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Microbial Testing Laboratories
    • 7.7.1. Microbial Testing Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Bioburden Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Bioburden Testing Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Charles River Laboratories
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. SGS Societe Generale de Surveillance SA.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. WuXi AppTec
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. BD
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. North American Science Associates, LLC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Nelson Laboratories, LLC
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Thermo Fisher Scientific Inc
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. BIOMERIEUX
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Pacific Biolabs
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives